ArticleFrontiers in oncology2025

A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancer.

Yosuke Miura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.